Innovating Works

NVGH

Desconocido
Vacc-iNTS: Advancing a GMMA based vaccine against invasive non typhoidal salmonellosis through Phase 1 trial in... Invasive non-typhoidal Salmonellosis (iNTS) is an important emerging Neglected Infectious Disease in resource-poor settings of sub-Saharan A...
2019-04-30 - 2026-07-31 | Financiado
GENDRIVAX: Genome driven vaccine development for bacterial infections GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL tramitó un FP7: The aim of the GENDRIVAX (GENome-DRIVen Vaccine) scientific programme is to develop novel prophylactic vaccines against invasive bacterial d...
Financiado
STOPENTERICS: Vaccination against Shigella and ETEC novel antigens novel approaches GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL participó en un FP7: To contribute to the development of vaccines against Shigella and ETEC for children of the developing world, STOPENTERICS will provide novel...
Financiado
ADITEC: Advanced Immunization Technologies GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL participó en un FP7: Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious...
Financiado
VADER: Vaccine Design and Immune Responses GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL participó en un FP7: The successful development of new vaccines depends on the interaction of industrial expertise for vaccine design and engineering with academ...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.